JPND Launches €21 Million Call to Support Health and Social Care Research and Innovation
Current research suggests strong potential for improving quality of life for those living with neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, with novel health and social care concepts and innovations focusing on the preservation of dignity, independence and social inclusion. Nevertheless, the availability and quality of such services vary considerably across Europe and beyond.
In this context, JPND today announced a new call inviting multi-national research teams to submit proposals for ambitious, innovative and multi-disciplinary collaborative projects that address health and social care at both the macro level of systems and infrastructures and the individual level of patients, carers and families.
“Over the past decades, most of the funding has been allocated to basic and translational research with the aim of discovering new treatments,” said Professor Philippe Amouyel, Chair of JPND. “ However, immediate impactful developments also come from health and social care research and innovation, including new insights that point to the potential for improved patient empowerment, civic participation, and quality of life. That’s why twenty JPND countries have earmarked €21 million to support multi-national research consortia investigating the strengths and weaknesses of different models of care and potential pathways to implementing improved, evidence-based approaches. Our hope is that this work will lead to the adoption of novel health promotion strategies that will reduce the impact of disease for patients as well as for their families and carers.”
Proposals submitted under this call, which is open to applicants in 20 countries , must relate to any or several of the following neurodegenerative diseases: Alzheimer’s disease and other dementias, Parkinson’s disease and related disorders, prion diseases, motor neuron diseases, Huntington’s disease, spinocerebellar ataxia and spinal muscular atrophy. Research projects may include, but are not limited to, one or several of the following areas:
- Care pathways and programmes using the potential of patient involvement
- Factors influencing progression and prognosis of disease
- Outcome measures for patients and their informal carers
- Palliative care for patients
- Cost-effectiveness and affordability of interventions including ethical concerns
For more information about the call, please visit www.jpnd.eu .
Grace Kiser, +33(0)781343204
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
SMITHS-DETECTION24.1.2018 10:02 | pressemeddelelse
Düsseldorf Airport to Deploy Next Generation ECAC Standard 3 EDS Screening Technology from Smiths Detection
GSMA24.1.2018 10:02 | pressemeddelelse
GSMA Announces Nominees for 2018 GLOMO Awards
TELIA-CARRIER24.1.2018 10:02 | pressemeddelelse
GleSYS Tap Into Telia Carrier Backbone to Increase Capacity and Support Growth Plans
CA-INTEGRAL23.1.2018 23:02 | pressemeddelelse
Integral Expands Cryptocurrency Market Data Services to Include 14 Cryptocurrencies and 16 Exchanges
VISTA-GROUP23.1.2018 22:59 | pressemeddelelse
Kimbal Riley to Become Vista Group CEO
NY-INTERNATIONAL-FLAVORS23.1.2018 18:03 | pressemeddelelse
IFF Breaks Ground on Flavors/Fragrances Site in Sri City, India
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum